about
Single acute stress-induced progesterone and ovariectomy alter cardiomyocyte contractile function in female rats.Progestogens used in postmenopausal hormone therapy: differences in their pharmacological properties, intracellular actions, and clinical effectsMedroxyprogesterone acetate and dihydrotestosterone induce coronary hyperreactivity in intact male rhesus monkeys.Prevention of coronary hyperreactivity in preatherogenic menopausal rhesus monkeys by transdermal progesterone.Effects of a monophasic combined oral contraceptive containing nomegestrol acetate and 17β-oestradiol compared with one containing levonorgestrel and ethinylestradiol on haemostasis, lipids and carbohydrate metabolism.Pharmacology of different progestogens: the special case of drospirenone.Treating vasomotor symptoms of menopause: the nurse practitioner's perspective.Vascular effects of estrogen and progestins and risk of coronary artery disease: importance of timing of estrogen treatment.Different cardiovascular effects of progestins according to structure and activity.Differential effects of synthetic progestagens on neuron survival and estrogen neuroprotection in cultured neurons.Progestogen effects at vascular level: the endothelial cells.Haemostatic and metabolic impact of estradiol pills and drospirenone-containing ethinylestradiol pills vs. levonorgestrel-containing ethinylestradiol pills: A literature review.Metabolic Adaptations in Pregnancy: A Review.Serum lipids and apolipoproteins in Greek postmenopausal women: association with estrogen, estrogen-progestin, tibolone and raloxifene therapy.Do gene-environment interactions influence fasting plasma lipids? A study of twins.Hormone therapy modulates ET(A) mRNA expression in the aorta of ovariectomised New Zealand White rabbits.Influence of oral contraceptives on lipid profile and paraoxonase and commonly hepatic enzymes activities.Progesterone increases nitric oxide synthesis in human vascular endothelial cells through activation of membrane progesterone receptor-α.
P2860
Q33725423-64B7F6A6-1497-485E-B0CC-65DC26DB8A4DQ34317537-F893AFD8-1AFD-453F-819F-8848822B55C1Q34655424-55544856-CC35-44AD-BD3A-A0E002C7C74BQ34655430-B6910AB9-41B2-4A5D-941B-82ED7D2911F1Q35599726-5B7F35F2-6DD7-41A0-B391-C09516B0C719Q36276322-5A3BABB5-B413-49C5-929A-C11E9D1BA889Q36753044-DBC8AC6E-C3D5-41D3-8C12-0C1EE5BB34A7Q37174271-4C5482F6-D69A-4D63-95FE-2B447F223A3EQ37610407-101B64B4-5FDB-45D9-8219-19E3E5BB87E5Q37637693-06DD505B-BE5F-4F21-A7E8-623D445B2BF0Q38471461-CE36D356-D9F5-46DE-BC36-933A26010F29Q38501601-5BEBC97F-344A-4FBB-AADC-815B2269456AQ39180508-C0DA7490-3E06-4F20-BA79-DF408E98C324Q44571336-64B9D197-518C-4D50-A434-B947D75F73EAQ45067414-8792675B-E539-4AB7-882E-191028D1756DQ46060638-12B743DE-84FE-439E-B1DD-F2A3323510AAQ48146245-304B3587-15ED-4E81-991B-2682F2F3BB64Q53571454-45649C71-86BD-45FC-A740-3C8AE8FF695E
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Progestins and cardiovascular risk markers.
@ast
Progestins and cardiovascular risk markers.
@en
Progestins and cardiovascular risk markers.
@nl
type
label
Progestins and cardiovascular risk markers.
@ast
Progestins and cardiovascular risk markers.
@en
Progestins and cardiovascular risk markers.
@nl
prefLabel
Progestins and cardiovascular risk markers.
@ast
Progestins and cardiovascular risk markers.
@en
Progestins and cardiovascular risk markers.
@nl
P1433
P1476
Progestins and cardiovascular risk markers.
@en
P2093
Sitruk-Ware R
P304
P356
10.1016/S0039-128X(00)00174-4
P577
2000-10-01T00:00:00Z